Archive for the ‘Arena Pharmaceuticals Inc’ Category

Arena Pharmaceuticals

April 8th, 2013 | Posted in 2013, Arena Pharmaceuticals Inc

Has started Phase I clinical testing of a potential treatment for diseases that affect the body’s immune systems.  In this preliminary test, Arena will evaluate the safety, tolerability and reaction to the drugs using up to 64 healthy adult volunteers.

Posted in 2013, Arena Pharmaceuticals Inc | No Comments »

Arena Pharmaceuticals Inc

May 21st, 2012 | Posted in 2012, Arena Pharmaceuticals Inc

Arena Pharmaceuticals Inc. – San Diego:  The company’s weight loss pill has gained the backing of an advisory panel, which puts the obesity drug in line for U.S. approval almost 2 year after regulators rejected it as too risky!! The FDA voted recently 18-4 that the benefits of the pill, known as Lorcaserin, outweigh the [...]

Posted in 2012, Arena Pharmaceuticals Inc | No Comments »

Arena Pharmaceuticals Inc

March 25th, 2010 | Posted in Arena Pharmaceuticals Inc

Arena Pharmaceuticals Inc. is a biotechnology company in the development state.  The company announced that it has started early-stage studies of potential narcolepsy (a sleep disorder) and cataplexy (a sudden loss of muscle tone for people with Narcolepsy) treatment.

Posted in Arena Pharmaceuticals Inc | No Comments »